Skip to main content

Table 4 Mean receptor densities in the caudate nucleus of control subjects and patients with progressive supranuclear palsy

From: Multireceptor fingerprints in progressive supranuclear palsy

 

Progressive supranuclear palsy vs. control subjects

Progressive supranuclear palsy, frontal vs. nonfrontal presentation

Progressive supranuclear palsy, mild vs. severe tau pathology

Receptor

Control subjects

Patients

p Value

Frontal

Nonfrontal

p Value

Mild

Severe

p Value

AMPA

607 (108)

583 (228)

0.749

477 (248)

665 (184)

0.102

631 (220)

503 (238)

0.290

Kainate

879 (61)

800 (73)

0.007

783 (70)

813 (76)

0.426

793 (68)

812 (85)

0.628

NMDA

1216 (42)

1218 (115)

0.951

1210 (122)

1224 (118)

0.823

1251 (116)

1163 (99)

0.413

mGlu2/3

9295 (625)

9416 (1455)

0.799

8735 (1746)

9945 (980)

0.100

9502 (1272)

9272 (1843)

0.771

GABAA

1273 (164)

1091 (203)

0.021

986 (214)

1173 (160)

0.065

1133 (178)

1021 (239)

0.304

GABAB

2477 (299)

2684 (397)

0.155

2529 (402)

2805 (370)

0.177

2788 (382)

2511 (389)

0.184

BZ

1684 (136)

1458 (330)

0.023

1463 (422)

1454 (266)

0.956

1635 (284)

1163 (121)

0.002

pBZ

1759 (89)

2050 (347)

0.005

2127 (392)

1989 (317)

0.450

2154 (365)

1876 (251)

0.123

M1

1174 (35)

922 (379)

0.018

968 (351)

886 (418)

0.686

904 (412)

952 (353)

0.815

M2

567 (56)

497 (127)

0.063

467 (140)

520 (119)

0.422

501 (158)

490 (54)

0.049

M3

1755 (36)

1740 (255)

0.829

1753 (309)

1731 (223)

0.869

1751 (299)

1723 (183)

0.843

nACh

200 (42)

105 (43)

<0.001

97 (30)

111 (52)

0.522

119 (42)

82 (38)

0.094

α1

339 (28)

338 (53)

0.945

314 (51)

356 (50)

0.123

331 (47)

349 (65)

0.543

α2

467 (65)

510 (92)

0.199

502 (98)

516 (94)

0.767

498 (91)

531 (99)

0.500

5-HT1A

129 (16)

135 (27)

0.543

139 (28)

132 (28)

0.646

139 (33)

128 (12)

0.428

5-HT2

1069 (100)

976 (142)

0.074

976 (138)

976 (153)

0.996

1048 (105)

856 (115)

0.004

D1

291 (8)

332 (49)

0.010

341 (30)

326 (61)

0.456

349 (53)

305 (25)

0.085

D2

885 (50)

818 (103)

0.057

765 (108)

860 (82)

0.066

845 (99)

774 (102)

0.188

A1

1522 (239)

1952 (288)

<0.001

1966 (327)

1942 (274)

0.786

1938 (349)

1977 (167)

0.806

A2A

1814 (195)

2105 (327)

0.014

2112 (409)

2100 (273)

0.944

2093 (391)

2124 (212)

0.863

  1. Abbreviations: A 1 Adenosine receptor type 1, A 2A Adenosine receptor type 2A, α 1 Adrenoceptor type 1, α 2 Adrenoceptor type 2, AMPA α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, BZ γ-Aminobutyric acid type A-associated benzodiazepine-binding site, D1 Dopamine receptor type 1, D2 Dopamine receptor type 2, GABA A γ-Aminobutyric acid receptor type A, GABA B γ-Aminobutyric acid receptor type B, 5-HT 1A Serotonin receptor type 1A, 5-HT 2 Serotonin receptor type 2, M 1 , M 2 , M 3 Muscarinic cholinergic receptor types 1, 2, 3, mGlu2/3 Metabotropic glutamate receptor type 2/3, nACh Nicotinic cholinergic receptor of the α4/β2 type, NMDA N-methyl-d-aspartate, pBZ Peripheral benzodiazepine receptor
  2. Absolute densities (SD) in femtomoles per milligram of protein as well as p values for the post hoc tests (significant values are highlighted in boldface type) are provided for each receptor type